Through its collaboration with WuXi, Aceso Therapeutics aims to accelerate and secure ACT-101’s CMC development, supported by WuXi’s recognized global expertise and comprehensive capabilities in pharmaceutical development.
Through its collaboration with WuXi, Aceso Therapeutics aims to accelerate and secure ACT-101’s CMC development, supported by WuXi’s recognized global expertise and comprehensive capabilities in pharmaceutical development.